Found: 12
Select item for more details and to access through your institution.
Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2423390, doi. 10.1001/jamanetworkopen.2024.23390
- By:
- Publication type:
- Article
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 2025, doi. 10.1038/s41416-023-02477-7
- By:
- Publication type:
- Article
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/4719194
- By:
- Publication type:
- Article
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 12, p. 2355, doi. 10.1002/1878-0261.13141
- By:
- Publication type:
- Article
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1732, doi. 10.1634/theoncologist.2020-0518
- By:
- Publication type:
- Article
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID‐19 Outbreak.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1013, doi. 10.1634/theoncologist.2020-0316
- By:
- Publication type:
- Article
When the Modern Was the Tradition: Carlo Mollino at Sestriere and His Last Unpublished Project (1973).
- Published in:
- Architectural Histories, 2022, v. 10, n. 1, p. 1, doi. 10.16995/ah.8641
- By:
- Publication type:
- Article
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date.
- Published in:
- Breast Cancer: Targets & Therapy, 2018, v. 10, p. 23, doi. 10.2147/BCTT.S134641
- By:
- Publication type:
- Article
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1038/s41523-020-00197-2
- By:
- Publication type:
- Article
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00559-6
- By:
- Publication type:
- Article
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1374547
- By:
- Publication type:
- Article
Recent advances in triple negative breast cancer: the immunotherapy era.
- Published in:
- 2019
- By:
- Publication type:
- journal article